Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Nina, Čas Sikošek"'
Autor:
Monika Sobočan, Maja Turk, Pija Čater, Nina Čas Sikošek, Bojana Crnobrnja, Iztok Takač, Darja Arko
Publikováno v:
Journal of International Medical Research, Vol 48 (2020)
Objective Clinical and pathological characteristics of triple negative breast cancer (TNBC) treatment are required for escalation or de-escalation of treatment because of a lack of druggable targets. This study aimed to identify the factors affecting
Externí odkaz:
https://doaj.org/article/ca6477537b9f4e2996560ba0265aa0b1
Autor:
Simona Borštnar, Cvetka Grašič-Kuhar, Erika Matos, Erik Škof, Nina Čas-Sikošek, Jožica Červek, Tanja Čufer
Publikováno v:
Onkologija, Vol 14, Iss 2, Pp 116-119 (2010)
Približno desetina bolnic z rakom dojk ima v tumorju izražene hormonske receptorje (HR) in hkrati čezmerno izražen protein in/ali pomnožen gen HER2. Čeprav pozitivni HR napovedujejo dober odgovor na hormonsko zdravljenje, pa izsledki predklini
Externí odkaz:
https://doaj.org/article/af62aa4ea8a5417bb1e6760a30cf5a9c
Autor:
Iztok Takač, Tanja Čufer, Borut Gorišek, Nina Čas Sikošek, Robert Bali, Damijana Bosilj, Simona Borštnar, Maja Lampelj, Maja Ravnik, Rajko Kavalar, Nina Fokter, Darja Arko
Publikováno v:
Zdravniški Vestnik, Vol 80, Iss 5 (2011)
Background: This paper describes the role of urokinase-type plasminogen activator (uPA) and its inhibitor, PAI-1, in breast cancer invasion and metastasis. These two parts of fibrinolytic system were the first novel tumor biological factors to be val
Externí odkaz:
https://doaj.org/article/c2d05997a1044ca69ec437854d84dbff
Publikováno v:
Zdravniški Vestnik, Vol 73, Iss 4 (2004)
Background. Endometrial cancer is the most frequent genital malignancy among women in Slovenia. During diagnostic and treatment procedures as well as follow-up of endometrial cancer patients after treatment, a lot of data is generated. However, its a
Externí odkaz:
https://doaj.org/article/676184f84cfb453690f5c8d9d7caa916
Publikováno v:
Slovenian Journal of Public Health, Vol 56, Iss 3, Pp 185-192 (2017)
Slovenian Journal of Public Health
Slovenian Journal of Public Health
Breast cancer is increasingly diagnosed in the early stages without regional nodal involvement. The aim of the present study was to determine the 5-year overall (OS) and breast cancer specific survival (BCSS) for patients with node-negative breast ca
Publikováno v:
Zdravniški Vestnik, Vol 72, Iss 0 (2003)
Background. Lymphatics are the main pathway for distant spread of endometrial cancer. The node groups most commonly involved are located along the iliac and retroperitoneal vessels. Therefore, pelvic and aortic lymphadenectomy are performed for stagi
Externí odkaz:
https://doaj.org/article/fefe09c8e9884b81990d61223ee5ced6
Publikováno v:
Breast Care. 11:406-410
Background: The natural course of traditionally prognostically unfavorable human epidermal growth factor receptor 2 (HER2)-positive breast cancer has been changed by anti-HER2 therapy. It is not clear whether the prognosis for HER2-positive patients
Autor:
Nadia Harbeck, Nina Čas Sikošek, Steffen Kahlert, Maja Ravnik, Darja Arko, Shani Paluch-Shimon, Nina Fokter Dovnik, Andraž Dovnik, Theresa M. Kolben, Giulia Galli, Thomas Kolben, Sibylle Loibl, Serena Di Cosimo, Isabelle Himsl, Elisa Zanardi, Fedro A. Peccatori, Iztok Takač, Jutta Engel, Sven Mahner, Filippo de Braud, Giacomo Bregni, Arpine Gevorgyan, Elżbieta Senkus-Konefka, Rachel Wuerstlein, Tom Degenhardt
Publikováno v:
Breast Care. 11:449-452
Autor:
B. Crnobrnja, Monika Sobočan, Darja Arko, Iztok Takač, Maja Turk, Pija Čater, Nina Čas Sikošek
Publikováno v:
The Journal of International Medical Research
Journal of International Medical Research, Vol 48 (2020)
Journal of International Medical Research, Vol 48 (2020)
Objective Clinical and pathological characteristics of triple negative breast cancer (TNBC) treatment are required for escalation or de-escalation of treatment because of a lack of druggable targets. This study aimed to identify the factors affecting
Publikováno v:
European journal of obstetrics, gynecology, and reproductive biology. 216
Objective An increasing number of breast-conserving surgeries (BCS) has lead clinicians to the dilemma how to provide patients with the best pathological, short-term and long-term outcomes, while at the same time improving the cosmetic outcome and th